Exhibit 99.1
| NEWS RELEASE Media Contact: David Carter, dwcarter@magellanhealth.com, (860) 507-1909 |
MAGELLAN HEALTH SERVICES REPORTS
THIRD QUARTER 2013 FINANCIAL RESULTS
- Updates 2013 Guidance -
AVON, Conn. — October 24, 2013 — Magellan Health Services Inc. (NASDAQ: MGLN) today reported financial results for the third quarter 2013, as summarized below. For the quarter ended September 30, 2013, the company reported net revenue of $873.6 million, segment profit of $59.2 million, and net income of $47.2 million or $1.70 per diluted common share. Segment profit represents income from operations before stock compensation expense, depreciation and amortization, interest expense, interest income, gain on sale of assets, special charges or benefits and income taxes.
Financial Results
|
| Three Months Ended September 30 |
| Nine Months Ended September 30 |
| ||||||||||||
(Millions, except per share results) |
| 2013 |
| 2012 |
| Increase/ |
| 2013 |
| 2012 |
| Increase/ |
| ||||
Revenue |
| $ | 873.6 |
| $ | 798.4 |
| 9.4 | % | $ | 2,538.1 |
| $ | 2,377.1 |
| 6.8 | % |
Segment Profit |
| 59.2 |
| 69.4 |
| (14.7 | )% | 203.5 |
| 189.6 |
| 7.3 | % | ||||
Net Income |
| 47.2 |
| 66.3 |
| (28.8 | )% | 106.8 |
| 114.0 |
| (6.3 | )% | ||||
Earnings Per Share |
| 1.70 |
| 2.36 |
| (28.0 | )% | 3.87 |
| 4.10 |
| (5.6 | )% | ||||
As of September 30, 2013, the company had unrestricted cash and investments of $355.9 million, prior to the closing of the Partners Rx transaction on October 1.
“Magellan had a solid quarter, and we made significant progress in advancing our growth strategies,” said Barry M. Smith, chief executive officer.
“This is a particularly dynamic time as we continue to transform the company and position it for the changing health care market and for future growth. In Magellan Complete Care, we received notice of a contract award from the state of Florida to launch a Medicaid specialty plan for individuals with Serious Mental Illness (SMI), and we signed definitive agreements for a strategic investment in AlphaCare of New York, a newly-licensed Medicaid Managed Long Term Care HMO and Medicare Plan. We also completed the acquisition of Partners Rx, a full-service commercial pharmacy benefits management company with a strong focus on health plans and self-funded employers.
“We’ve added two highly experienced business leaders to our executive team. Bob Field, President and CEO of Partners Rx, has become the CEO of Magellan Pharmacy Solutions, which includes all of our pharmacy products. Additionally, Sam Srivastava, has been appointed to the new position of CEO of Magellan Plan Services, which includes our core
commercial and public sector behavioral health businesses, as well as Magellan Complete Care. Bob and Sam are dynamic leaders with significant track records of success and innovation, and they, along with our entire executive team, are committed to taking the steps necessary to best position the company for continued future growth.”
Outlook
“Given the results to date, the expected fourth quarter impact of the Partners Rx acquisition, and the extension of our Maricopa County, AZ contract through March 31, 2014, we are now expecting our full year 2013 guidance for net revenue in the range of $3.5 to $3.7 billion, net income of $118 to $136 million, and segment profit in the upper half of our range of $245 to $265 million,” said Jonathan N. Rubin, chief financial officer. “Taking into account the impact of share repurchase activity through October 21st, 2013, but not considering any potential future share repurchases, our guidance range for fully diluted EPS is estimated to be $4.28 to $4.93.
“Looking ahead, after adjusting the current 2013 segment profit guidance range for $15 million of net favorable, out-of-period adjustments, we currently expect that we will have moderately lower segment profit in 2014. We will provide detailed 2014 guidance during our December call.”
Earnings Results Conference Call
Management will host a conference call at 10:00 a.m. Eastern Time on Thursday, October 24, 2013. To participate in the conference call, interested parties should call 1-800-857-1812 and reference the pass code Third Quarter Earnings Call 2013 approximately 15 minutes before the start of the call. The conference call will also be available via a live Webcast at Magellan’s investor relations page at www.MagellanHealth.com.
About Magellan Health Services: Headquartered in Avon, Conn., Magellan Health Services Inc. is a leading specialty health care management organization with expertise in managing behavioral health, radiology, and pharmacy benefits programs, as well as integrated health care programs for special populations. Magellan delivers innovative solutions to improve quality outcomes and optimize the cost of care for those we serve. As of September 30, 2013, Magellan’s customers include health plans, employers and government agencies, serving approximately 33.9 million members in our behavioral health business, 17.5 million members in our radiology benefits management segment, and approximately 9.2 million members in our medical pharmacy management product. In addition, the pharmacy solutions segment served 39 health plans and employers, 25 states and the District of Columbia, and several pharmaceutical manufacturers. For more information, visit www.MagellanHealth.com.
Cautionary Statement
This release contains forward-looking statements within the meaning of the Securities Exchange Act of 1934 and the Securities Act of 1933, as amended, which involve a number of risks and uncertainties. All statements, other than statements of historical information provided herein, may be deemed to be forward-looking statements including, without limitation, statements regarding estimates of 2013 revenue, net income, segment profit, out-of-period adjustments, and earnings per share, 2014 segment profit, and strategy and growth. These statements are based on management’s analysis, judgment, belief and expectation only as of the date hereof, and are subject to uncertainty and changes in
circumstances. Without limiting the foregoing, the words “believes,” “anticipates,” “plans,” “expects,” “may,” “should,” “could,” “estimate,” “intend” and other similar expressions are intended to identify forward-looking statements. Actual results could differ materially due to, among other things, the possible election of certain of the company’s customers to manage the health care services of their members directly; changes in rates paid to and/or by the company by customers and/or providers; higher utilization of health care services by the company’s risk members; delays, higher costs or inability to implement new business or other company initiatives; the impact of changes in the contracting model for Medicaid contracts; termination or non-renewal of customer contracts; the impact of new or amended laws or regulations; governmental inquiries; litigation; competition; operational issues; health care reform; and general business conditions. Additional factors that could cause actual results to differ materially from those reflected in the forward-looking statements include, but are not limited to, the risks discussed in the “Risk Factors” section included within the company’s Annual Report on Form 10-K for the year ended December 31, 2012, filed with the Securities and Exchange Commission on February 28, 2013, and the company’s subsequent Quarterly Reports on Form 10-Q filed during 2013. Readers are cautioned not to place undue reliance on these forward-looking statements. The company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date of this release. Segment profit information referred to herein may be considered a non-GAAP financial measure. Further information regarding this measure, including the reasons management considers this information useful to investors, are included in the company’s most recent Annual Report on Form 10-K and on subsequent Form 10-Qs.
Media Contact
David W. Carter
860-507-1909
DWCarter@MagellanHealth.com
Investor Contact
Renie Shapiro
877-645-6464
RShapiro@MagellanHealth.com
# # #
MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
(In thousands, except per share amounts)
|
| Three Months Ended September 30, |
| Nine months Ended September 30, |
| ||||||||
|
| 2012 |
| 2013 (1) |
| 2012 |
| 2013 (1) |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Net revenue: |
|
|
|
|
|
|
|
|
| ||||
Managed care and other |
| $ | 711,092 |
| $ | 775,957 |
| $ | 2,114,149 |
| $ | 2,255,748 |
|
Dispensing |
| 87,345 |
| 97,641 |
| 262,974 |
| 282,359 |
| ||||
Total net revenue |
| 798,437 |
| 873,598 |
| 2,377,123 |
| 2,538,107 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Cost and expenses: |
|
|
|
|
|
|
|
|
| ||||
Cost of care |
| 516,238 |
| 570,187 |
| 1,543,361 |
| 1,642,944 |
| ||||
Cost of goods sold |
| 81,662 |
| 91,853 |
| 245,555 |
| 265,440 |
| ||||
Direct service costs and other operating expenses (2) |
| 135,574 |
| 156,834 |
| 412,496 |
| 440,958 |
| ||||
Depreciation and amortization |
| 15,239 |
| 17,654 |
| 45,172 |
| 50,770 |
| ||||
Interest expense |
| 537 |
| 789 |
| 1,713 |
| 2,191 |
| ||||
Interest income |
| (350 | ) | (291 | ) | (1,619 | ) | (1,002 | ) | ||||
|
| 748,900 |
| 837,026 |
| 2,246,678 |
| 2,401,301 |
| ||||
Income before income taxes |
| 49,537 |
| 36,572 |
| 130,445 |
| 136,806 |
| ||||
(Benefit) provision for income taxes |
| (16,725 | ) | (10,660 | ) | 16,420 |
| 30,036 |
| ||||
Net income |
| 66,262 |
| 47,232 |
| 114,025 |
| 106,770 |
| ||||
Other comprehensive income (loss) (3) |
| 120 |
| 110 |
| 208 |
| (37 | ) | ||||
Comprehensive income |
| $ | 66,382 |
| $ | 47,342 |
| $ | 114,233 |
| $ | 106,733 |
|
|
|
|
|
|
|
|
|
|
| ||||
Weighted average number of common shares outstanding — basic |
| 27,521 |
| 26,990 |
| 27,346 |
| 26,976 |
| ||||
Weighted average number of common shares outstanding — diluted |
| 28,042 |
| 27,704 |
| 27,835 |
| 27,563 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Net income per common share — basic |
| $ | 2.41 |
| $ | 1.75 |
| $ | 4.17 |
| $ | 3.96 |
|
Net income per common share — diluted |
| $ | 2.36 |
| $ | 1.70 |
| $ | 4.10 |
| $ | 3.87 |
|
(1) For a more detailed discussion of Magellan’s results for the quarterly period ended September 30, 2013, refer to the Company’s Quarterly Report on Form 10-Q, which will be filed with the SEC on Thursday, October 24, 2013, and the live broadcast or taped replay of the Company’s earnings conference call on Thursday, October 24, 2013, which will be available at www.MagellanHealth.com.
(2) Includes stock compensation expense of $4,468 and $4,524 for the three months ended September 30, 2012 and 2013, respectively, and $13,935 and $14,764 for the nine months ended September 30, 2012 and 2013, respectively.
(3) Net of income tax provision (benefit) of $78 and $74 for the three months ended September 30, 2012 and 2013, respectively, and $134 and $(25) for the nine months ended September 30, 2012 and 2013, respectively.
MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)
|
| Nine Months Ended September 30, |
| ||||
|
| 2012 |
| 2013 (1) |
| ||
|
|
|
|
|
| ||
Cash flows from operating activities: |
|
|
|
|
| ||
Net income |
| $ | 114,025 |
| $ | 106,770 |
|
|
|
|
|
|
| ||
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
| ||
Depreciation and amortization |
| 45,172 |
| 50,770 |
| ||
Non-cash interest expense |
| 544 |
| 552 |
| ||
Non-cash stock compensation expense |
| 13,935 |
| 14,764 |
| ||
Non-cash income tax expense (benefit) |
| 12,395 |
| (164 | ) | ||
Non-cash amortization on investments |
| 5,373 |
| 7,273 |
| ||
Cash flows from changes in assets and liabilities, net of effects from acquisitions of businesses: |
|
|
|
|
| ||
Restricted cash (2) |
| (59,777 | ) | 17,987 |
| ||
Accounts receivable, net |
| 604 |
| (19,231 | ) | ||
Pharmaceutical inventory |
| (2,002 | ) | (1,680 | ) | ||
Other assets |
| (4,218 | ) | (9,781 | ) | ||
Accounts payable and accrued liabilities |
| (17,854 | ) | 6,685 |
| ||
Medical claims payable and other medical liabilities |
| 37,422 |
| 16,144 |
| ||
Tax contingencies |
| (34,616 | ) | (22,981 | ) | ||
Other |
| 654 |
| 4,174 |
| ||
Net cash provided by operating activities |
| 111,657 |
| 171,282 |
| ||
|
|
|
|
|
| ||
Cash flows from investing activities: |
|
|
|
|
| ||
Capital expenditures |
| (53,049 | ) | (42,091 | ) | ||
Purchase of investments |
| (197,525 | ) | (235,946 | ) | ||
Maturity of investments |
| 215,150 |
| 233,723 |
| ||
Other |
| — |
| (7,900 | ) | ||
Net cash used in investing activities |
| (35,424 | ) | (52,214 | ) | ||
|
|
|
|
|
| ||
Cash flows from financing activities: |
|
|
|
|
| ||
Payments to acquire treasury stock |
| — |
| (49,462 | ) | ||
Proceeds from exercise of stock options and warrants |
| 13,092 |
| 24,548 |
| ||
Payments on capital lease obligations |
| — |
| (2,310 | ) | ||
Other |
| 135 |
| 484 |
| ||
Net cash provided by (used in) financing activities |
| 13,227 |
| (26,740 | ) | ||
|
|
|
|
|
| ||
Net increase in cash and cash equivalents |
| 89,460 |
| 92,328 |
| ||
Cash and cash equivalents at beginning of period |
| 119,862 |
| 189,464 |
| ||
Cash and cash equivalents at end of period |
| $ | 209,322 |
| $ | 281,792 |
|
(1) The Company’s Quarterly Report on Form 10-Q for the nine months ended September 30, 2013 will be filed with the SEC on Thursday, October 24, 2013.
(2) Includes the net shift of restricted funds between cash and investments that results in an operating cash flow change that is directly offset by an investing cash flow change. During the nine months ended September 30, 2012, restricted investments of $27,421 were shifted to restricted cash that resulted in an operating cash flow use, with restricted cash of $33,610 shifted to restricted investments during the nine months ended September 30, 2013 that resulted in an operating cash flow source.
MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES
CONSOLIDATED OPERATING RESULTS BY BUSINESS SEGMENT
(Unaudited)
(In thousands)
|
| Three Months Ended September 30, |
| Nine Months Ended September 30, |
| ||||||||
|
| 2012 |
| 2013 (1) |
| 2012 |
| 2013 (1) |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Managed care and other revenue |
|
|
|
|
|
|
|
|
| ||||
- Commercial |
| $ | 176,713 |
| $ | 190,655 |
| $ | 535,464 |
| $ | 578,030 |
|
- Public Sector |
| 407,265 |
| 445,260 |
| 1,206,289 |
| 1,266,739 |
| ||||
- Radiology Benefits Management |
| 88,126 |
| 94,125 |
| 253,809 |
| 277,118 |
| ||||
- Pharmacy Solutions (2) |
| 54,421 |
| 63,008 |
| 171,846 |
| 182,418 |
| ||||
- Elimination (2) |
| (15,433 | ) | (17,091 | ) | (53,259 | ) | (48,557 | ) | ||||
Total managed care and other revenue |
| 711,092 |
| 775,957 |
| 2,114,149 |
| 2,255,748 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Dispensing revenue - Pharmacy Solutions |
| 87,345 |
| 97,641 |
| 262,974 |
| 282,359 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Cost of care |
|
|
|
|
|
|
|
|
| ||||
- Commercial |
| 100,973 |
| 118,022 |
| 323,992 |
| 354,520 |
| ||||
- Public Sector (2) |
| 358,959 |
| 382,913 |
| 1,058,384 |
| 1,095,694 |
| ||||
- Radiology Benefits Management |
| 58,080 |
| 65,403 |
| 166,364 |
| 182,212 |
| ||||
- Pharmacy Solutions |
| 13,659 |
| 20,940 |
| 47,880 |
| 59,075 |
| ||||
- Elimination (2) |
| (15,433 | ) | (17,091 | ) | (53,259 | ) | (48,557 | ) | ||||
Total cost of care |
| 516,238 |
| 570,187 |
| 1,543,361 |
| 1,642,944 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Cost of goods sold - Pharmacy Solutions |
| 81,662 |
| 91,853 |
| 245,555 |
| 265,440 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Direct service costs and other operating expenses |
|
|
|
|
|
|
|
|
| ||||
- Commercial |
| 43,007 |
| 47,032 |
| 127,825 |
| 129,823 |
| ||||
- Public Sector |
| 22,948 |
| 27,826 |
| 66,850 |
| 82,403 |
| ||||
- Radiology Benefits Management |
| 14,045 |
| 13,990 |
| 41,113 |
| 41,224 |
| ||||
- Pharmacy Solutions |
| 27,565 |
| 32,281 |
| 83,532 |
| 93,216 |
| ||||
- Corporate |
| 28,009 |
| 35,705 |
| 93,176 |
| 94,292 |
| ||||
Total direct service costs and other operating expenses |
| 135,574 |
| 156,834 |
| 412,496 |
| 440,958 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Stock compensation expense (3) |
|
|
|
|
|
|
|
|
| ||||
- Commercial |
| (293 | ) | (124 | ) | (830 | ) | (390 | ) | ||||
- Public Sector |
| (278 | ) | (259 | ) | (835 | ) | (833 | ) | ||||
- Radiology Benefits Management |
| (419 | ) | (384 | ) | (1,179 | ) | (1,275 | ) | ||||
- Pharmacy Solutions |
| (238 | ) | (198 | ) | (704 | ) | (898 | ) | ||||
- Corporate |
| (3,240 | ) | (3,559 | ) | (10,387 | ) | (11,368 | ) | ||||
Total stock compensation expense |
| (4,468 | ) | (4,524 | ) | (13,935 | ) | (14,764 | ) | ||||
|
|
|
|
|
|
|
|
|
| ||||
Segment profit (loss) |
|
|
|
|
|
|
|
|
| ||||
- Commercial |
| 33,026 |
| 25,725 |
| 84,477 |
| 94,077 |
| ||||
- Public Sector |
| 25,636 |
| 34,780 |
| 81,890 |
| 89,475 |
| ||||
- Radiology Benefits Management |
| 16,420 |
| 15,116 |
| 47,511 |
| 54,957 |
| ||||
- Pharmacy Solutions |
| 19,118 |
| 15,773 |
| 58,557 |
| 47,944 |
| ||||
- Corporate and Elimination |
| (24,769 | ) | (32,146 | ) | (82,789 | ) | (82,924 | ) | ||||
Total segment profit |
| $ | 69,431 |
| $ | 59,248 |
| $ | 189,646 |
| $ | 203,529 |
|
|
|
|
|
|
|
|
|
|
| ||||
Reconciliation of segment profit to income before income taxes: |
|
|
|
|
|
|
|
|
| ||||
Segment profit |
| $ | 69,431 |
| $ | 59,248 |
| $ | 189,646 |
| $ | 203,529 |
|
Stock compensation expense |
| (4,468 | ) | (4,524 | ) | (13,935 | ) | (14,764 | ) | ||||
Depreciation and amortization |
| (15,239 | ) | (17,654 | ) | (45,172 | ) | (50,770 | ) | ||||
Interest expense |
| (537 | ) | (789 | ) | (1,713 | ) | (2,191 | ) | ||||
Interest income |
| 350 |
| 291 |
| 1,619 |
| 1,002 |
| ||||
Income before income taxes |
| $ | 49,537 |
| $ | 36,572 |
| $ | 130,445 |
| $ | 136,806 |
|
(1) The Company’s Quarterly Report on Form 10-Q for the nine months ended September 30, 2013 will be filed with the SEC on Thursday, October 24, 2013.
(2) Public Sector has subcontracted with Pharmacy Solutions to provide pharmacy benefits management services on a limited risk basis for one of Public Sector’s customers. As such, revenue and cost of care related to this intersegment arrangement are eliminated.
(3) Stock compensation expense is included in direct service costs and other operating expenses; however, this amount is excluded from the computation of segment profit since it is managed on a consolidated basis.